Skip to main content
While the exorbitant costs of health care associated infections (HAIs) have been repeatedly cited as a prime reason for prevention — second only to the higher calling of patient safety — an inconvenient truth was recently revealed by researchers at Johns Hopkins University in Baltimore. Looking at central line related bloodstream infections — which kill some 28,000 patients annually — they found a disturbing disincentive to prevent CLABSIs at the very heart of the health care system — profit.

Blood money: Hospitals reap profit on CLABSIs

While the exorbitant costs of health care associated infections (HAIs) have been repeatedly cited as a prime reason for prevention second only to the higher calling of patient safety an inconvenient truth was recently revealed by researchers at Johns Hopkins University in Baltimore. Looking at central line related bloodstream infections which kill some 28,000 patients annually they found a disturbing disincentive to prevent CLABSIs at the very heart of the health care system profit.